Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, Akin, Querbes, William, De, Soma, Qin, June, Frank-Kamenetsky, Maria, Jayaprakash, K. Narayanannair, Jayaraman, Muthusamy, Rajeev, Kallanthottathil G +17 more·2010·Molecular Therapy

DOI 10.1038/mt.2010.85

Cited by (1,002)

Items 401–500 of 1,002

Brain gene therapy with Trojan horse lipid nanoparticles
William M. Pardridge · 2023 · Trends in Molecular Medicine
Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys
Colby S. Shemesh, Rosie Z. Yu, Hans J. Gaus, Sarah Greenlee, Noah M. Post, Karsten Schmidt, Michael T. Migawa, Punit P. Seth, Thomas A. Zanardi, Thazha P. Prakash et al. · 2016 · Molecular Therapy — Nucleic Acids
Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
Christophe Delehedde, Luc Even, Patrick Midoux, Chantal Pichon, Federico Perche · 2021 · Pharmaceutics
Small interfering RNA from the lab discovery to patients' recovery
Marie Caillaud, Mévidette El Madani, Liliane Massaad-Massade · 2020 · Journal of Controlled Release
Surface properties modulate protein corona formation and determine cellular uptake and cytotoxicity of silver nanoparticles
Marianna Barbalinardo, Jessika Bertacchini, Linda Bergamini, Maria Sara Magarò, Luca Ortolani, Alessandra Sanson, Carla Palumbo, Massimiliano Cavallini, Denis Gentili · 2021 · Nanoscale
RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary M. Sethna, Vinod P. Balachandran · 2024 · Cancer Cell
Using macropinocytosis for intracellular delivery of therapeutic nucleic acids to tumour cells
Arpan S. Desai, Morag Rose Hunter, Alexander N. Kapustin · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo
Meirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, Eleni Anastasiadou, Roberto De Luca, Jihoon Lim, Anastasia Khvorova, Frank John Slack · 2019 · Molecular Therapy — Nucleic Acids
Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid
Yuta Suzuki, Hiroshi Ishihara · 2016 · International Journal of Pharmaceutics
Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment
Ricardo Gaspar, Filipe Coelho, Bruno F. B. Silva · 2020 · Molecules
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, Algera, Stoffel, Markus · 2022 · Nature Reviews Drug Discovery
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
Jie Tang, Larry Cai, Chuanfei Xu, Si Sun, Yuheng Liu, Joseph Rosenecker, Shan Guan · 2022 · Nanomaterials
Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth
Teruki Yanagi, Kiyoshi Tachikawa, Rachel P. Wilkie-Grantham, Asami Hishiki, Ko Nagai, Ellen Toyonaga, Pad Chivukula, Shu‐ichi Matsuzawa · 2016 · Molecular Therapy — Nucleic Acids
Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues
Yulia Eygeris, Mohit Gupta, Jeonghwan Kim, Antony Jozić, Milan Gautam, Jonas Renner, Dylan Nelson, Elissa Bloom, Adam Tuttle, Jonathan Stoddard et al. · 2024 · Proceedings of the National Academy of Sciences
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
Razan Masarwy, Lior Stotsky‐Oterin, Aviad Elisha, Inbal Hazan‐Halevy, Dan Peer · 2024 · Advanced Drug Delivery Reviews
Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro
Demian van Straten, Helena Sork, Luuk van de Schepop, Rowan Frunt, Kariem Ezzat, Raymond Michel Schiffelers · 2024 · Journal of Controlled Release
Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles
Sangeetha Aula, Samyuktha Lakkireddy, Kaiser Jamil, Atya Kapley, A. V. N. Swamy, Lakkireddy Harivardhan Reddy · 2015 · RSC Advances
Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain
Hidetaka Akita, Mina Tamaru, Kazuaki Kajimoto, Yusuke Sato, Hiroto Hatakeyama, Hideyoshi Harashima, Taichi Nakatani · 2014 · International Journal of Nanomedicine
Bioavailability and release of bioactive components from nanocapsules
Seid Mahdi Jafari, Iman Katouzian, Hamid Rajabi, Mohammad Ganje · 2017 · Elsevier eBooks
Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides
Philip Grossen, Michaela Portmann, Erich Koller, Martina Duschmalé, Tanja Minz, Sabine Sewing, Nikhil Janak Pandya, Sabine Kux van Geijtenbeek, Axel Ducret, Eric-André Kusznir et al. · 2020 · European Journal of Pharmaceutics and Biopharmaceutics
Pharmacokinetics and Biodistribution of LCP Nanoparticles
Yang Liu · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins
Yu Ping Tian, Matthew Tirrell, James L. LaBelle · 2022 · Advanced Healthcare Materials
Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1
Yalan Wang, Qiubing Chen, Shuang Wu, Xinyu Sun, Runting Yin, Zhen Ouyang, Hao Yin, Yuan Wei · 2023 · Acta Pharmaceutica Sinica B
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
Shuying Feng, Xin Xie, Junjie Liu, Aifang Li, Qianqian Wang, Dandan Guo, Shuxuan Li, Yalan Li, Zilong Wang, Tao Guo et al. · 2023 · Journal of Nanobiotechnology
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida · 2024 · RNA Biology
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
Fan Wu, Nei Li, Yi Xiao, Rohan Palanki, Hannah M. Yamagata, Michael J. Mitchell, Xuexiang Han · 2025 · Small Methods
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications
Máté Vadovics, Wenchen Zhao, Emily F. Daley, Kieu Lam, Owen M. Daly, Khalid Rashid, Hailey R. Lee, Petra Schreiner, Kendall A. Lundgreen, Brian T. Gaudette et al. · 2025 · Nature Nanotechnology
Targeted polymeric nanoparticles for cancer gene therapy
Jayoung Kim, David R. Wilson, Camila Gadens Zamboni, Jordan J. Green · 2015 · Journal of drug targeting
Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
Shoshy Mizrahy, Inbal Hazan‐Halevy, Niels Dammes, Dalit Landesman‐Milo, Dan Peer · 2017 · Molecular Therapy
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
Woitok, Marius Maximilian, Zoubek, Miguel Eugenio, Doleschel, Dennis, Bartneck, Matthias, Mohamed, Mohamed Ramadan, Kießling, Fabian, Lederle, Wiltrud, Trautwein, Christian, Cubero, Francisco Javier · 2020 · Cell Death & Disease
A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery
Randall A. Meyer, G. Patrick Hussmann, Norman C. Peterson, José Luís Santos, Anthony D. Tuesca · 2021 · International Journal of Pharmaceutics
Targeting strategies for mRNA delivery
Randall A. Meyer, Sarah Y. Neshat, Jordan J. Green, José Luís Santos, Anthony D. Tuesca · 2022 · Materials Today Advances
Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver
Nadine Saber, Mariona Estapé Sentí, Raymond Michel Schiffelers · 2024 · Human Gene Therapy
Attacking the genome: emerging siRNA nanocarriers from concept to clinic
Christopher A. Alabi, Arturo J. Vegas, Daniel G. Anderson · 2012 · Current Opinion in Pharmacology
In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
Tsunamasa Watanabe, Hiroto Hatakeyama, Chiho Matsuda, Yusuke Sato, Masayuki Sudoh, Asako Takagi, Yuichi Hirata, Takahiro Ohtsuki, Masaaki Arai, Kazuaki Inoue et al. · 2014 · Scientific Reports
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
Daniel Scherman, Antoine Rousseau, Pascal Bigey, Virginie Escriou · 2017 · Gene Therapy
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, Ming Qian Wei · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Kimura, Taishi, Leal, Joseph M., Simpson, Adrian, Warner, Nikole L., Berube, Bryan J., Archer, Jacob F., Park, Stephanie, Kurtz, Ryan, Hinkley, Troy, Nicholes, Katrina et al. · 2023 · Molecular Therapy
Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo
Kazuaki Kajimoto, Yusuke Sato, Takashi Nakamura, Yuma Yamada, Hideyoshi Harashima · 2014 · Journal of Controlled Release
Discovery of Ketal‐Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery
Kai Lv, Zhenlei Yu, Jing Wang, Na Li, Apeng Wang, Tiezheng Xue, Qixin Wang, Yanqin Shi, Lu Han, Wei Qin et al. · 2024 · Advanced Science
CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery
Tyler Ellis Papp, Jianhao Zeng, Hamna Shahnawaz, Awurama Akyianu, Laura Breda, Amir Yadegari, Joseph Steward, Ruiqi Shi, Qin Li, Barbara L. Mui et al. · 2025 · Molecular Therapy
Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives
Xiaochi Li, Junli Li, Jiazheng Wei, Weixin Du, Cheng Su, Xiaobin Shen, Aihua Zhao, Miao Xu · 2025 · MedComm
The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
Xin Ming, Kyle A. Carver, MICHAEL S. FISHER, Romain Noël, Jean‐Christophe Cintrat, Daniel Gillet, Julien Barbier, Canhong Cao, John A. Bauman, Rudolph L. Juliano · 2013 · Nucleic Acids Research
Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery
Hidetaka Akita, Yuki Noguchi, Hiroto Hatakeyama, Yusuke Sato, Kota Tange, Yuta Nakai, Hideyoshi Harashima · 2015 · ACS Biomaterials Science & Engineering
Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
Genc Basha, Mina Ordobadi, Wilder R Scott, Andrew Gregory Cottle, Yan Liu, Haitang Wang, Pieter R. Cullis · 2016 · Molecular Therapy — Nucleic Acids
Emerging Concepts of Nanobiotechnology in mRNA Delivery
Yue Wang, Chengzhong Yu · 2020 · Angewandte Chemie International Edition
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
Thijs Van de Vyver, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Advanced Drug Delivery Reviews
Interactions of Apolipoproteins with Lipid-Based Nanoparticles
Paul Dalhaimer, Brice Florey, Sami Isaac · 2023 · ACS Nano
Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies
Valeria Nele, Virginia Campani, Seyedeh Alia Moosavian, Giuseppe De Rosa · 2024 · Advanced Drug Delivery Reviews
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, María J. Blanco‐Prieto · 2024 · Advanced Drug Delivery Reviews
Lipopolyplexes comprising imidazole/imidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection
Cristine Gonçalves, Mathieu Berchel, Marie-Pierre Gosselin, Virginie Malard, Hervé Cheradame, Paul‐Alain Jaffrès, Philippe Guégan, Chantal Pichon, Patrick Midoux · 2013 · International Journal of Pharmaceutics
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
Chao Liang, Jie Li, Cheng Chang Lu, Duoli Xie, Jin Liu, Chuanxin Zhong, Xiaohao Wu, Rongchen Dai, Huarui Zhang, Daogang Guan et al. · 2019 · Nature Communications
Engineering Micro–Nanomaterials for Biomedical Translation
Yaping Chen, Marı́a Alba, Terence Tieu, Ziqiu Tong, Rajpreet Singh Minhas, David Andre Rudd, Nicolas Hans Voelcker, Anna Cifuentes‐Rius, Roey Elnathan · 2021 · Advanced NanoBiomed Research
The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA
Haitang Wang, Yuen Yi C. Tam, Sam Chen, Josh Zaifman, Roy van der Meel, Marco A. Ciufolini, Pieter R. Cullis · 2016 · Molecular Therapy
Nanomedicines for the Delivery of Biologics
John C. Wahlich, Arpan S. Desai, Francesca Greco, Kathryn J. Hill, Arwyn Tomos Jones, Randall J. Mrsny, Gianfranco Pasut, Yvonne Perrie, F. Philipp Seib, Leonard William Seymour et al. · 2019 · Pharmaceutics
The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS
Yusuke Sato, Takashi Nakamura, Yuma Yamada, Hideyoshi Harashima · 2020 · Journal of Controlled Release
Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B
Yuanyu Huang, Shuquan Zheng, Zhaoxu Guo, Xavier de Mollerat du Jeu, Xing‐Jie Liang, Zhiwei Yang, Hongyan Zhang, Shan Gao, Zicai Liang · 2022 · Signal Transduction and Targeted Therapy
Next generation self-replicating RNA vectors for vaccines and immunotherapies
Parinaz Aliahmad, Shigeki Joseph Miyake-Stoner, Andrew J. Geall, Nathaniel S. Wang · 2022 · Cancer Gene Therapy
An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA
Roger C. Adami, Shaguna Seth, Pierrot Harvie, Rachel E. Johns, Renata Fam, Kathy L. Fosnaugh, Tianying Zhu, Ken Farber, Michael McCutcheon, Thomas T. Goodman et al. · 2011 · Molecular Therapy
pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes
Kazuki Hashiba, Yusuke Sato, Hideyoshi Harashima · 2017 · Journal of Controlled Release
Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy
Kelly Godbout, Jacques P. Tremblay · 2022 · Pharmaceutics
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Pei Huang, Hongzhang Deng, Changrong Wang, Yongfeng Zhou, Xiaoyuan Shawn Chen · 2023 · Advanced Materials
Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications
Manikandan Dhayalan, Wei Wang, S.U. Mohammed Riyaz, Rakshi Anuja Dinesh, Jayashree Shanmugam, Santiagu Stephen Irudayaraj, Antony Stalin, Jayant P Giri, Saurav Mallik, Ruifeng Hu · 2024 · 3 Biotech
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Girish Lokras, Thomas Rønnemoes Bobak, Saahil Sandeep Baghel, Federica Sebastiani, Camilla Foged · 2024 · Advanced Drug Delivery Reviews
An apolipoprotein E modified liposomal nanoparticle: Ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells
Mina Tamaru, Hidetaka Akita, Kazuaki Kajimoto, Yusuke Sato, Hiroto Hatakeyama, Hideyoshi Harashima · 2014 · International Journal of Pharmaceutics
Fluorocarbon Modified Low-Molecular-Weight Polyethylenimine for siRNA Delivery
Mark E. Johnson, D. Judy Shon, Brian M. Guan, Joseph P. Patterson, Nathan J. Oldenhuis, Alexander C. Eldredge, Nathan C. Gianneschi, Zhibin Guan · 2016 · Bioconjugate Chemistry
Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity
Lingfeng Tong, Zhangbing Chen, Yangyang Li, Xinxia Wang, Changjie Yang, Yakui Li, Yemin Zhu, Ying Lu, Qi Liu, Nannan Xu et al. · 2024 · Cell Metabolism
More than a delivery system: the evolving role of lipid-based nanoparticles
Senjuti Karmaker, Plinio D. Rosales, Barath Tirumuruhan, Amartya Viravalli, Natalie Boehnke · 2025 · Nanoscale
Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment
Lígia Catarina Gomes-da-Silva, Adriana O. Santos, Luís M. Bimbo, Vera Moura, Jose Silva Ramalho, Maria C. Pedroso de Lima, Sérgio Simões, João Nuno Moreira · 2012 · International Journal of Pharmaceutics
Nanoparticle-Mediated In Situ Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy
Adam Alexander Walters, Gemma Santacana-Font, Jin Li, Nadia Routabi, Yue Qin, Nathalie Claes, Sara Bals, Julie T.-W. Wang, Khuloud T. Al‐Jamal · 2021 · ACS Nano
mRNA Vaccines: Why Is the Biology of Retroposition Ignored?
Tomislav Domazet‐Lošo · 2022 · Genes
Polyplex designs for improving the stability and safety of RNA therapeutics
Satoshi Uchida, Chun Yin Jerry Lau, Makoto Oba, Kanjiro Miyata · 2023 · Advanced Drug Delivery Reviews
Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation
Jeonghwan Kim, Antony Jozić, Elissa Bloom, Brian Jones, Michael Marra, Namratha Turuvekere Vittala Murthy, Yulia Eygeris, Gaurav Sahay · 2024 · ACS Nano
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
Querbes, William, Bogorad, Roman L., Moslehi, Javid, Wong, Jamie, Chan, Amy Y., Bulgakova, Elena, Kuchimanchi, Satya, Akinc, Akin, Fitzgerald, Kevin, Koteliansky, Victor et al. · 2012 · Blood
Emerging treatments for amyloidosis
Rabya Hussain Sayed, Philip Nigel Hawkins, Helen Jane Lachmann · 2014 · Kidney International
Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery
Ricarda C. Steffens, Ernst Wagner · 2022 · Pharmaceutical Research
On the mechanism of tissue-selective gene delivery by lipid nanoparticles
Seigo Kimura, Hideyoshi Harashima · 2023 · Journal of Controlled Release
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers
Anan Yaghmur, Jesper Østergaard, Huiling Mu · 2023 · Advanced Drug Delivery Reviews
Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA
Mengjie Zhang, Abid Hussain, Bo Hu, Haiyin Yang, Chunhui Li, Shuai Guo, Xiaofeng Han, Bei Li, Yunlu Dai, Yuhong Cao et al. · 2024 · Nature Communications
To Be Targeted: Is the Magic Bullet Concept a Viable Option for Synthetic Nucleic Acid Therapeutics?
Manfred Ogris, Ernst Wagner · 2011 · Human Gene Therapy
HDL and microRNA therapeutics in cardiovascular disease
Danielle L. Michell, Kasey C. Vickers · 2016 · Pharmacology & Therapeutics
Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo
Cory D. Sago, Melissa P. Lokugamage, Gwyneth N. Lando, Naima Djeddar, Nirav N. Shah, Chris Syed, Anton V. Bryksin, James E. Dahlman · 2018 · Nano Letters
The potential of RNA-based therapy for kidney diseases
Tjessa Bondue, Lambertus P. van den Heuvel, Elena N. Levtchenko, Roland E. Brock · 2022 · Pediatric Nephrology
Extracellular Vesicle and Lipoprotein Interactions
Raluca E. Ghebosu, Jenifer Pendiuk Gonçalves, Joy Wolfram · 2023 · Nano Letters
Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA
Yuen Yi C. Tam, Sam Chen, Josh Zaifman, Ying K. Tam, Paulo J C Lin, Steven Ansell, Michel Roberge, Marco A. Ciufolini, Pieter R. Cullis · 2012 · Nanomedicine Nanotechnology Biology and Medicine
Therapeutic targeting strategies using endogenous cells and proteins
Neha N. Parayath, Mansoor M. Amiji · 2017 · Journal of Controlled Release
Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistribution
Takashi Nakamura, Yuma Yamada, Yusuke Sato, Ikramy A. Khalil, Hideyoshi Harashima · 2019 · Biomaterials
RNA Therapeutics: How Far Have We Gone?
Maria Francisca Coutinho, Liliana Matos, Juliana Inês Santos, Sandra Alves · 2019 · Advances in experimental medicine and biology
The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice
Wanyue Zhang, Annabelle Pfeifle, Casey Lansdell, Grant E. Frahm, Jonathon Cecillon, Levi A. Tamming, Caroline Gravel, Jun Gao, Sathya N. Thulasi Raman, Lisheng Wang et al. · 2023 · Vaccines
Protein-based nanoparticles for therapeutic nucleic acid delivery
Feyisayo Eweje, Michelle L. Walsh, Kiran Ahmad, Vanessa Ibrahim, Assma Alrefai, Jiaxuan Chen, Elliot L. Chaikof · 2024 · Biomaterials
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Runxuan Chu, Yi Wang, Jianglong Kong, Ting Shuang Pan, Yani Yang, Jun Feng He · 2024 · Journal of Materials Chemistry B
Membrane Fusion‐Based Drug Delivery Liposomes Transiently Modify the Material Properties of Synthetic and Biological Membranes
Jayna Hammond, Ceri J. Richards, YouBeen Ko, Thijs Jonker, Christoffer Åberg, Wouter H. Roos, Rafael B. Lira · 2025 · Small
Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics
Marian E. Gindy, Anthony M. Leone, James J. Cunningham · 2012 · Expert Opinion on Drug Delivery
Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine
Kevin J. Polach, Majed M. Matar, Jennifer S. Rice, Gregory Slobodkin, Jeff Sparks, Richard Congo, Angela Rea-Ramsey, Diane McClure, Elaine Brunhoeber, Monika Krampert et al. · 2011 · Molecular Therapy
Nanomaterials-Based siRNA Delivery: Routes of Administration, Hurdles and Role of Nanocarriers
Nitin Gupta, Divya Bharti Rai, Ashok Kumar Jangid, Deep Pooja, Hitesh Kulhari · 2019 · Springer eBooks
Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material
Hiroki Tanaka, Nae Takata, Yu Sakurai, Tokuyuki Yoshida, Takao Inoué, Shinya Tamagawa, Yuta Nakai, Kota Tange, Hiroki Yoshioka, Masatoshi Maeki et al. · 2021 · Pharmaceutics
Bioinspired Lipid Nanocarriers for RNA Delivery
Alex Golubovic, Shannon Tsai, Bowen Li · 2023 · ACS Bio & Med Chem Au
Key Design Features of Lipid Nanoparticles and Electrostatic Charge-Based Lipid Nanoparticle Targeting
Vijay Gyanani, Roshan Goswami · 2023 · Pharmaceutics
Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity
Nuthan Vikas Bathula, Josh J. Friesen, Irafasha C. Casmil, Christopher J. Wayne, Suiyang Liao, Shekinah K. V. Soriano, Chia-Hao Ho, Anneke Strumpel, Anna K. Blakney · 2024 · Journal of Controlled Release
Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies
Britta Schneider, Michael Grote, Matthias John, Alexander K. Haas, Birgit Bramlage, Ludger M lckenstein, Kerstin Jahn‐Hofmann, Frieder Bauss, Weijun Cheng, Rebecca Croasdale et al. · 2012 · Molecular Therapy — Nucleic Acids